These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2662454)

  • 1. Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.
    Sterns EE; Cochran AJ
    Surg Gynecol Obstet; 1989 Jul; 169(1):81-98. PubMed ID: 2662454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
    Bussolati G
    Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
    Förster C; Bässler R
    Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monoclonal antibodies in the diagnosis of breast carcinoma].
    Beketić-Oresković L; Novak D
    Lijec Vjesn; 1992; 114(5-8):157-60. PubMed ID: 1343051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of epithelial antigens in diagnosis and staging of breast cancer].
    Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
    Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies in mammary carcinoma].
    Pancino G; Roseto A
    Medicina (B Aires); 1988; 48(3):311-20. PubMed ID: 3073296
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of B72.3 staining in "suspicious" fine needle aspiration biopsies of the breast.
    Pohoresky J; Yazdi HM
    Acta Cytol; 1991; 35(2):254-5. PubMed ID: 2028702
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers in human breast cancer].
    Takami H; Shikata J
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
    Dauplat MM; Penault-Llorca F
    Ann Pathol; 2009 Jun; 29(3):228-32. PubMed ID: 19619831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoclonal antibodies in diagnosis of breast cancer].
    Karsten U
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):987-92. PubMed ID: 1776290
    [No Abstract]   [Full Text] [Related]  

  • 12. [The place of tumor markers in breast and gynecologic neoplasms].
    Gosselin P; Cazin JL; Demaille MC; Sulman C
    Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies in oncology: applications in diagnosis, prognosis and prediction of response to therapy on tissue specimens].
    Penault-Llorca FM; Balaton AJ
    Bull Cancer; 2000 Nov; 87(11):794-803. PubMed ID: 11125288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies raised to colorectal carcinoma antigens.
    Makin CA
    Ann R Coll Surg Engl; 1986 Nov; 68(6):298-301. PubMed ID: 2434014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
    Kunz J; Schmidt A
    Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies in the detection and treatment of breast cancer micrometastases.
    Neville AM; Monaghan P; McIlhinney RA; Gusterson B; Coombes RC
    Monogr Pathol; 1986; (27):193-205. PubMed ID: 3762554
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.
    Rasmussen BB; Pedersen BV; Thorpe SM; Hilkens J; Hilgers J; Rose C
    Cancer Res; 1985 Mar; 45(3):1424-7. PubMed ID: 3971385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.